Squarepoint
KRRO icon

Squarepoint’s Korro Bio KRRO Stock Holding History

Squarepoint’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-412
Closed -$106K – 3209
2021
Q4 		$106K Buy
+412
New +$125K ﹤0.01% 2905
2021
Q3 		– Sell
-218
Closed -$109K – 3187
2021
Q2 		$109K Sell
218
-1,460
-87% -$713K ﹤0.01% 2998
2021
Q1 		$797K Buy
+1,678
New +$3.26M ﹤0.01% 1689
2020
Q1 		– Sell
-432
Closed -$379K – 2209
2019
Q4 		$379K Buy
+432
New +$336K ﹤0.01% 1914

Other funds holding KRRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Squarepoint's KRRO Position: Q1 2022 in Review

Squarepoint sold out of Korro Bio (KRRO) in Q1 2022, closing a stake of 412 shares — an estimated $106K sold.

Squarepoint first reported a position in KRRO in Q4 2019 and held it in 4 quarters. The position peaked at $797K in Q1 2021. 85 funds tracked by Wall St. Rank hold KRRO as of Q1 2022.

  • Squarepoint reported no remaining Korro Bio position as of Q1 2022 after selling out during the quarter.
  • Squarepoint sold 412 Korro Bio shares in Q1 2022, an estimated $106K.
  • Squarepoint first reported a position in Korro Bio in Q4 2019 and held it in 4 quarters.
  • Squarepoint's Korro Bio position peaked at $797K in Q1 2021.
  • 85 funds tracked by Wall St. Rank held Korro Bio as of Q1 2022.

Based on Squarepoint's 13F filing for Q1 2022, filed 16 May 2022.